abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to oxazolopyramidine compounds of formula I, where A represents O; R 1 is selected from phenyl or pyrimidine, which are optionally substituted with R 11 ; R 2 represents phenyl, which is optionally substituted wby 1-3 ring carbon atoms with similar or different substituents R 22 , R 11 represents halogen; R 22 is selected from hydroxy group, (C 1 -C 4 )-alkyl, which is optionallysubstituted with 1-3 atoms of fluorine, (C 1 -C 4 )-alkyloxy, (C 1 -C 4 )-alkyl-S(O) m -; m equals 2. Invention also relates to pharmaceutical composition, which contains formula I compounds, and to method of obtaining formula I compounds. n EFFECT: formula I compounds, intended for activation of EDG-1 receptor and applied for wound healing. n 15 cl, 2 tbl, 2 ex |